An optic nerve that has an injury cannot be fixed, so usually, if there is vision loss from ischemic optic neuropathy, it is permanent. Those with badly damaged optic nerves usually can still see ...

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

For the past 20 years treatment with high-dose corticosteroids and optic nerve decompression have been favored. However, recent evidence has raised questions regarding the value of these treatments.

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...

Optic nerve tumour successfully removed during crainiotomy but peripheral damage from before never improved.Is there any new treatment in progress or available for optic nerve damage? Answer::Hi there ...

A new study from researchers at Karolinska Institutet suggests that a specific vitamin supplement may help slow down or even ...

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ('NurExone' or t ...

Two large studies from the University of Southern Denmark suggest that the diabetes medication Ozempic doubles the risk of developing NAION, a rare but serious condition that damages the optic nerve.

From Dr. Sharma, "Glaucoma may develop even when vision seems perfectly normal. Sometimes, for example, with normal-tension glaucoma, optic nerve damage happens even with normal intraocular pressure." ...

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who don’t use the drug. In Grauslund’s study, researchers examined a ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a ...